RESUMO
Polyamines (PAs) are ubiquitous small aliphatic polycations important for growth, development, and environmental stress responses in plants. Here, we demonstrate that exogenous application of spermine (Spm) and spermidine (Spd) induced cell death at high concentrations, but primed resistance against the necrotrophic fungus Botrytis cinerea in Arabidopsis. At low concentrations, Spm was more effective than Spd. Treatments with higher exogenous Spd and Spm concentrations resulted in a biphasic endogenous PA accumulation. Exogenous Spm induced the accumulation of H2O2 after treatment but also after infection with B. cinerea. Both Spm and Spd induced the activities of catalase, ascorbate peroxidase, and guaiacol peroxidase after treatment but also after infection with B. cinerea. The soluble sugars glucose, fructose, and sucrose accumulated after treatment with high concentrations of PAs, whereas only Spm induced sugar accumulation after infection. Total and active nitrate reductase (NR) activities were inhibited by Spm treatment, whereas Spd inhibited active NR at low concentrations but promoted active NR at high concentrations. Finally, γaminobutyric acid accumulated after treatment and infection in plants treated with high concentrations of Spm. Phenylalanine and asparagine also accumulated after infection in plants treated with a high concentration of Spm. Our data illustrate that Spm and Spd are effective in priming resistance against B. cinerea, opening the door for the development of sustainable alternatives for chemical pesticides.
Assuntos
Antifúngicos/farmacologia , Arabidopsis/efeitos dos fármacos , Botrytis/patogenicidade , Regulação da Expressão Gênica de Plantas/efeitos dos fármacos , Imunidade Vegetal/efeitos dos fármacos , Espermidina/farmacologia , Espermina/farmacologia , Arabidopsis/genética , Arabidopsis/imunologia , Arabidopsis/metabolismo , Ascorbato Peroxidases/genética , Ascorbato Peroxidases/imunologia , Asparagina/imunologia , Asparagina/metabolismo , Botrytis/imunologia , Catalase/genética , Catalase/imunologia , Resistência à Doença/efeitos dos fármacos , Resistência à Doença/genética , Frutose/imunologia , Frutose/metabolismo , Glucose/imunologia , Glucose/metabolismo , Peróxido de Hidrogênio , Nitrato Redutase/genética , Nitrato Redutase/imunologia , Peroxidase/genética , Peroxidase/imunologia , Fenilalanina/imunologia , Fenilalanina/metabolismo , Doenças das Plantas/imunologia , Doenças das Plantas/prevenção & controle , Reguladores de Crescimento de Plantas/farmacologia , Folhas de Planta/efeitos dos fármacos , Folhas de Planta/genética , Folhas de Planta/imunologia , Folhas de Planta/metabolismo , Sacarose/imunologia , Sacarose/metabolismo , Ácido gama-Aminobutírico/imunologia , Ácido gama-Aminobutírico/metabolismoRESUMO
OBJECTIVES: Various rheumatoid arthritis (RA) HLA-DRB-1 risk haplotypes have been regrouped under the shared epitope (SE) in position 70-74. The presence of Valine in position 11 (Val11) and phenylalanine in position 13 (Phe13) are also associated with RA, but it is impossible to differentiate their role compared with the SE since they are in strong linkage disequilibrium (LD) in humans. Similar to humans, certain macaques express the SE (H6). We analysed the effect of various DRB1 haplotypes on T-cell response to citrullinated peptides (Cit-P) in macaques. METHODS: Six H6 and six non-H6 macaques were immunized with four Cit-P. T-cell response was assessed using Interferon γ enzyme-linked immunospot. RESULTS: Animals developed a specific anti-Cit-P T-cell response. Surprisingly, H6 animals had a significantly lower T-cell response than non-H6. In macaques, the 70-74 SE and the Val11 are on separate haplotypes. Presence of Val11 was strongly associated with the anti-Cit-P T-cell response, whatever the 70-74 sequence was. This response was amplified in case of presence of Phe13. CONCLUSION: The absence of LD between Val11 and SE in macaques allowed us to demonstrate that the most important HLA positions to induce a T-cell response against Cit-P were Val11 and Phe13 and not the 70-74 SE.
Assuntos
Cadeias HLA-DRB1/genética , Peptídeos Cíclicos/imunologia , Fenilalanina/imunologia , Linfócitos T/imunologia , Valina/imunologia , Animais , Artrite Reumatoide/imunologia , Epitopos , Cadeias HLA-DRB1/imunologia , Haplótipos , Ativação Linfocitária/imunologia , MacacaRESUMO
In vitro immunization can to used to produce monoclonal antibodies(mAbs), but this technology is limited by poor reproducibility and the requirement of pre-immunized lymphocytes. To improve this approach, we recently developed a method for rapid generation of antigen-specific B cells. Here, we report the application of this system to the production of human IgGs against tumor necrosis factor (TNF). We expressed mutant proteins with site-specific incorporated p-nitrophenylalanine (pNO2Phe), which stimulated an in vitro immune response in human immune cells. After constructing an antigen-specific antibody library from in vitro immunized B cells identified by fluorescence-activated cell sorting, we demonstrated that many point mutation events of the variable region occurred in our step-by-step co-cultivation system for affinity maturation in vitro. To mimic the class switching, we panned for high-affinity antigen-binding fragments by the phage display method, assembled them and identified hTNF-neutralizing human IgGs. This approach may provide a general method for raising high-affinity monoclonal antibodies against self-proteins. Furthermore, it supports mechanistic understanding in breaking human self-tolerance with pNO2Phe.
Assuntos
Anticorpos Monoclonais/imunologia , Linfócitos B/imunologia , Imunoglobulina G/imunologia , Técnicas Imunológicas/métodos , Fenilalanina/análogos & derivados , Anticorpos Monoclonais/genética , Anticorpos Neutralizantes/imunologia , Especificidade de Anticorpos , Humanos , Fragmentos Fab das Imunoglobulinas/genética , Fragmentos Fab das Imunoglobulinas/imunologia , Imunoglobulina G/genética , Técnicas In Vitro , Biblioteca de Peptídeos , Fenilalanina/imunologia , Fator de Necrose Tumoral alfa/antagonistas & inibidoresRESUMO
Single B cell antibody technology is a method for isolating antigen-specific B cells from human peripheral blood and obtaining antibody genes in developing antibody drugs. However, owing to immune tolerance to autoantigen, human autoantigen-specific B cells are difficult to acquire by conventional single B cell technology. In this study, we constructed a nitrated T-cell epitope named NitraTh by incorporating p-nitrophenylalanine into a universal T helper epitope. NitraTh had enhanced ability to activate CD4+ T cells and can be recognized by CD4+ T cells with different HLA class II haplotypes. This NitraTh can also break immune tolerance to autoantigens, such as human epidermal growth factor receptor 2 (HER2) and cannabinoid receptor 1, and induce strong specific IgM+ B cell responses in vitro. HER2-NitraTh vaccine can also stimulate the generation of HER2-specific IgG+ B cells in human immune system mice, which was established by cotransplanting lymphocytes and autologous dendritic cells in immunodeficient mice. We obtained 30 fully human IgG antibody genes by sorting single B cells from the human immune system mice immunized with HER2-NitraTh vaccine. The analysis of antibody genes showed that sorted B cells underwent the extensive somatic mutation of the antibody genes. We randomly selected eight genes for cloning, six of which expressed antibodies that can bind to HER2. Hence, we provided a convenient and effective method in acquiring fully human antibody genes against self-proteins, which can be used in developing therapeutic antibody drugs.
Assuntos
Linfócitos B/imunologia , Linfócitos T CD4-Positivos/imunologia , Diferenciação Celular/imunologia , Epitopos de Linfócito T/imunologia , Fenilalanina/análogos & derivados , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Anticorpos/uso terapêutico , Autoantígenos/imunologia , Vacinas Anticâncer/imunologia , Linhagem Celular Tumoral , Células Dendríticas/imunologia , Epitopos de Linfócito T/química , Feminino , Antígenos de Histocompatibilidade Classe II , Humanos , Tolerância Imunológica , Imunoglobulina G/genética , Imunoglobulina M , Camundongos , Camundongos Endogâmicos NOD , Fenilalanina/química , Fenilalanina/imunologia , Receptor ErbB-2/imunologiaRESUMO
BACKGROUND: This study assessed the immunogenicity of pegvaliase (recombinant Anabaena variabilis phenylalanine [Phe] ammonia lyase [PAL] conjugated with polyethylene glycol [PEG]) treatment in adults with phenylketonuria (PKU) and its impact on safety and efficacy. METHODS: Immunogenicity was assessed during induction, upward titration, and maintenance dosing regimens in adults with PKU (nâ¯=â¯261). Total antidrug antibodies (ADA), neutralizing antibodies, immunoglobulin (Ig) M and IgG antibodies against PAL and PEG, IgG and IgM circulating immune complex (CIC) levels, complement components 3 and 4 (C3/C4), plasma Phe, and safety were assessed at baseline and throughout the study. Pegvaliase-specific IgE levels were measured in patients after hypersensitivity adverse events (HAE). FINDINGS: All patients developed ADA against PAL, peaking by 6â¯months and then stabilizing. Most developed transient antibody responses against PEG, peaking by 3â¯months, then returning to baseline by 9â¯months. Binding of ADA to pegvaliase led to CIC formation and complement activation, which were highest during early treatment. Blood Phe decreased over time as CIC levels and complement activation declined and pegvaliase dosage increased. HAEs were most frequent during early treatment and declined over time. No patient with acute systemic hypersensitivity events tested positive for pegvaliase-specific IgE near the time of the event. Laboratory evidence was consistent with immune complex-mediated type III hypersensitivity. No evidence of pegvaliase-associated IC-mediated end organ damage was noted. INTERPRETATION: Despite a universal ADA response post-pegvaliase administration, adult patients with PKU achieved substantial and sustained blood Phe reductions with a manageable safety profile. FUND: BioMarin Pharmaceutical Inc.
Assuntos
Anticorpos , Complexo Antígeno-Anticorpo , Hipersensibilidade a Drogas , Fenilalanina Amônia-Liase , Fenilcetonúrias , Proteínas Recombinantes , Adulto , Anticorpos/sangue , Anticorpos/imunologia , Complexo Antígeno-Anticorpo/sangue , Complexo Antígeno-Anticorpo/imunologia , Complemento C3/imunologia , Complemento C3/metabolismo , Complemento C4/imunologia , Complemento C4/metabolismo , Hipersensibilidade a Drogas/sangue , Hipersensibilidade a Drogas/imunologia , Feminino , Humanos , Masculino , Fenilalanina/sangue , Fenilalanina/imunologia , Fenilalanina Amônia-Liase/administração & dosagem , Fenilalanina Amônia-Liase/efeitos adversos , Fenilcetonúrias/sangue , Fenilcetonúrias/tratamento farmacológico , Fenilcetonúrias/imunologia , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/efeitos adversosRESUMO
Recombinant antibody libraries can provide a source of renewable and high-performing binders tailored for use in affinity proteomics. In this context, the process of generating site-specific 1:1 tagging/functionalization and/or orientated surface immobilization of antibodies has, however, proved to be challenging. Hence, novel ways of generating such engineered antibodies for use in affinity proteomics could have a major impact on array performance. In this study, we have further tailored the design of human recombinant scFv antibodies for site-specific photocoupling through the use of an unnatural amino acid (UAA) and the Dock'n'Flash technology. In more detail, we have generated the 2nd generation of scFvs carrying the photoreactive UAA p-benzoyl-l-phenylalanine (pBpa). Based on key properties, such as expression levels, activity, and affinity, a preferred choice of site for pBpa, located in the beginning of the C-terminal affinity-tag, was for the first time pin-pointed. Further, the results showed that pBpa mutated antibody could be site-specifically photocoupled to free and surface immobilized ß-cyclodextrin (an affinity ligand to pBpa). This paves the way for use of scFv antibodies, engineered for site-specific photochemical-based tagging, functionalization, and orientated surface immobilization, in affinity proteomics.
Assuntos
Afinidade de Anticorpos/imunologia , Benzofenonas/imunologia , Benzofenonas/metabolismo , Mutação/genética , Fenilalanina/análogos & derivados , Anticorpos de Cadeia Única/imunologia , Anticorpos de Cadeia Única/metabolismo , Humanos , Mutação/imunologia , Fenilalanina/imunologia , Fenilalanina/metabolismo , Engenharia de Proteínas/métodos , Proteômica/métodos , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologia , Proteínas Recombinantes de Fusão/metabolismo , Anticorpos de Cadeia Única/genética , beta-Ciclodextrinas/imunologia , beta-Ciclodextrinas/metabolismoRESUMO
Dry eye disease is an extremely common condition affecting millions worldwide. The underlying pathophysiological mechanism is thought to be localized inflammation of the ocular surface resulting in the localization of T cells at this surface followed by their activation and subsequent liberation of cytokines. This effect on T cells results from the binding of lymphocyte function-associated antigen-1 (LFA-1) located on T cells to intercellular adhesion molecule 1 (ICAM-1) expressed on inflamed epithelium and endothelium, and on T cells. Lifitegrast is a T-cell integrin antagonist designed to mimic ICAM-1, thus blocking the interaction of LFA-1 and ICAM-1. Lifitegrast enters the systemic circulation to a limited extent thus reducing the likelihood of unwanted systemic reactions. Clinical trials in over 2,500 subjects with dry eye disease have shown that 5.0% lifitegrast given by ocular instillation causes a significant reduction in objective and subjective signs and symptoms of the disease. These beneficial effects are associated with a relatively low incidence of unwanted effects, almost all local in nature. In light of these findings, lifitegrast was approved by the Food and Drug Administration (FDA) in 2016 for the treatment of dry eye disease, the first drug with this mechanism of action to be so approved.
Assuntos
Síndromes do Olho Seco , Antígeno-1 Associado à Função Linfocitária/imunologia , Fenilalanina/análogos & derivados , Sulfonas , Linfócitos T/imunologia , Anti-Inflamatórios/química , Anti-Inflamatórios/imunologia , Anti-Inflamatórios/farmacologia , Estudos Clínicos como Assunto , Avaliação Pré-Clínica de Medicamentos , Síndromes do Olho Seco/tratamento farmacológico , Síndromes do Olho Seco/imunologia , Síndromes do Olho Seco/fisiopatologia , Humanos , Inflamação/tratamento farmacológico , Inflamação/imunologia , Molécula 1 de Adesão Intercelular/imunologia , Soluções Oftálmicas , Fenilalanina/química , Fenilalanina/imunologia , Fenilalanina/farmacologia , Sulfonas/química , Sulfonas/imunologia , Sulfonas/farmacologiaRESUMO
In this study, we prepared polyclonal antibodies against anti-diabetic drug nateglinide (NTG), and established a sensitive chemiluminescent immunoassay (CLIA) to detect NTG in tablets and serum. Two kinds of immunogens were synthesized using ethylcarbodiimide (EDC)/hydroxysuccinimide (NHS) and carbonyldiimidazole (CDI)/4-dimethylaminopyridine (DMAP) as coupling reagents respectively. When activated by EDC/NHS, more molecules of NTG coupled with carrier protein in immunogens. A horseradish peroxidase (HRP)-luminol-H2O2 system with p-iodophenol enhancement was applied in the CLIA analysis. The antibodies in EDC/NHS group showed higher titer, sensitivity and wider detection linear range than those in CDI/DMAP group, and were chosen for next studies. The developed CLIA assay exhibited good selectivity towards NTG among structually similar analogs. The method could detect as low as 0.35 ng mL(-1) NTG in buffer, 2.1 ng mL(-1) NTG in serum and 0.84 ng mL(-1) NTG in tablets. The CLIA method provided consistent results with HPLC method (r=0.9986) in determination of NTG from 5.0 to 400 µg mL(-1). The CLIA method could detect 78 samples in one assay, and the samples need only dilution in pretreatment. As a summary, this research offers a sensitive assay for high-throughout screening of NTG in formulation control and pharmacokinetic studies.
Assuntos
Anticorpos/imunologia , Cicloexanos/análise , Imunoensaio/métodos , Limite de Detecção , Medições Luminescentes/métodos , Fenilalanina/análogos & derivados , Análise Química do Sangue , Química Farmacêutica , Cicloexanos/sangue , Cicloexanos/imunologia , Cinética , Nateglinida , Fenilalanina/análise , Fenilalanina/sangue , Fenilalanina/imunologia , ComprimidosRESUMO
PIWIL2, a member of PIWI/AGO family, is expressed in germline stem cells and precancerous stem cells, but not in adult somatic cells. PIWIL2 plays an important role in tumor development. It is considered as a cancertestis antigen (CT80). It has been reported that the spliced fragment of PIWIL2, PL2L60, was widely expressed in cancer cell lines. In this study, HLA-A2-restricted epitopes from PL2L60 were predicted by online tools. To improve the activity of the native epitope, a candidate peptide P281 with potent binding affinity was chosen to investigate the modification strategy. A series of aromatic amino acids were introduced to substitute the first residue of P281. Then, we tested the binding affinity and stability of the peptide analogs and their ability to elicit specific immune responses both in vitro and in vivo. Our results indicated that the cytotoxic T lymphocytes (CTLs) induced by [4-Cl-Phe1]P281 could elicit more potent activities than that of P281 and other analogs. The CTLs induced by this analog could lyze target cells in HLA-A2-restricted and antigen-specific manners. [4-Cl-Phe1]P281 also showed the best resistance against degradation in human serum. In conclusion, the introduction of the unnatural amino acid, 4-Cl-Phe, into the first position could enhance the activity of the native epitope to induce cytotoxic T lymphocytes. It might be a good strategy to modify other promising native epitopes. The novel epitopes identified in this study could be used as novel candidates to the immunotherapy of HLA-A2 positive patients with tumors expressing PL2L60.
Assuntos
Proteínas Argonautas/imunologia , Epitopos de Linfócito T/imunologia , Peptídeos/imunologia , Linfócitos T Citotóxicos/imunologia , Processamento Alternativo , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Antígenos de Neoplasias/genética , Antígenos de Neoplasias/imunologia , Antígenos de Neoplasias/metabolismo , Proteínas Argonautas/genética , Proteínas Argonautas/metabolismo , Western Blotting , Linhagem Celular , Citotoxicidade Imunológica/imunologia , Epitopos de Linfócito T/genética , Epitopos de Linfócito T/metabolismo , Regulação Neoplásica da Expressão Gênica , Antígeno HLA-A2/imunologia , Células HT29 , Humanos , Interferon gama/imunologia , Interferon gama/metabolismo , Células MCF-7 , Camundongos , Camundongos Transgênicos , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patologia , Peptídeos/genética , Peptídeos/metabolismo , Fenilalanina/genética , Fenilalanina/imunologia , Fenilalanina/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Linfócitos T Citotóxicos/metabolismoRESUMO
Here, we describe a novel method for L-phenylalanine analysis using a sandwich-type immunometric assay approach for use as a new method for amino acid analysis. To overcome difficulties of the preparation of high-affinity and selectivity monoclonal antibodies against L-phenylalanine and the inability to use sandwich-type immunometric assays due to their small molecular weight, three procedures were examined. First, amino groups of L-phenylalanine were modified by "N-Fmoc-L-cysteine" (FC) residues and the derivative (FC-Phe) was used as a hapten. Immunization of mice with bovine serum albumin/FC-Phe conjugate successfully yielded specific monoclonal anti-FC-Phe antibodies. Second, a new derivatization reagent, "biotin linker conjugate of FC-Phe N-succinimidyl ester" (FC(Biotin)-NHS), was synthesized to convert L-phenylalanine to FC-(Biotin)-Phe as a hapten structure. The biotin moiety linked to the thiol group of cysteine formed a second binding site for streptavidin/horseradish peroxidase (HRP) conjugates for optical detection. Third, a new semi-sandwich-type immunometric assay was established using pre-derivatized L-phenylalanine, the monoclonal anti-FC-Phe antibody, and streptavidin/HRP conjugate (without second antibody). Using the new "semi-sandwich" immunometric assay system, a detection limit of 35 nM (60 amol per analysis) and a detection range of 0.1-20 µM were attained using a standard L-phenylalanine solution. Rat plasma samples were analyzed to test reliability. Intra-day assay precision was within 6% of the coefficient of variation; inter-day variation was 0.1%. The recovery rates were from 92.4 to 123.7%. This is the first report of the quantitative determination of L-phenylalanine using a reliable semi-sandwich immunometric assay approach and will be applicable to the quantitative determination of other amino acids.
Assuntos
Imunoensaio/métodos , Fenilalanina/sangue , Animais , Anticorpos Monoclonais/imunologia , Feminino , Haptenos/imunologia , Limite de Detecção , Camundongos , Camundongos Endogâmicos BALB C , Fenilalanina/imunologia , Ratos , Ratos Sprague-DawleyRESUMO
L-amino acid oxidases (LAAO) are flavoproteins that catalyze the oxidative deamination of L-amino acids to a keto-acid along with the production of H2O2 and ammonia. Interleukin 4 induced gene 1 (IL4I1) is a secreted LAAO expressed by macrophages and dendritic cells stimulated by microbial derived products or interferons, which is endowed with immunoregulatory properties. It is the first LAAO described in mammalian innate immune cells. In this work, we show that this enzyme blocks the in vitro and in vivo growth of Gram negative and Gram positive bacteria. This antibiotic effect is primarily mediated by H2O2 production but is amplified by basification of the medium due to the accumulation of ammonia. The depletion of phenylalanine (the primary amino acid catabolized by IL4I1) may also participate in the in vivo inhibition of staphylococci growth. Thus, IL4I1 plays a distinct role compared to other antibacterial enzymes produced by mononuclear phagocytes.
Assuntos
Células Dendríticas/metabolismo , Escherichia coli/crescimento & desenvolvimento , Peróxido de Hidrogênio/metabolismo , L-Aminoácido Oxidase/metabolismo , Macrófagos/metabolismo , Staphylococcus aureus/crescimento & desenvolvimento , Linhagem Celular Tumoral , Células Dendríticas/imunologia , Escherichia coli/imunologia , Humanos , Peróxido de Hidrogênio/imunologia , L-Aminoácido Oxidase/imunologia , Macrófagos/imunologia , Fenilalanina/imunologia , Fenilalanina/metabolismo , Staphylococcus aureus/imunologiaRESUMO
The site-specific incorporation of the unnatural amino acid p-nitrophenylalanine (pNO(2)Phe) into autologous proteins overcomes self-tolerance and induces a long-lasting polyclonal IgG antibody response. To determine the molecular mechanism by which such simple modifications to amino acids are able to induce autoantibodies, we incorporated pNO(2)Phe, sulfotyrosine (SO(3)Tyr), and 3-nitrotyrosine (3NO(2)Tyr) at specific sites in murine TNF-α and EGF. A subset of TNF-α and EGF mutants with these nitrated or sulfated residues is highly immunogenic and induces antibodies against the unaltered native protein. Analysis of the immune response to the TNF-α mutants in different strains of mice that are congenic for the H-2 locus indicates that CD4 T-cell recognition is necessary for autoantibody production. IFN-γ ELISPOT analysis of CD4 T cells isolated from vaccinated mice demonstrates that peptides with mutated residues, but not the wild-type residues, are recognized. Immunization of these peptides revealed that a CD4 repertoire exists for the mutated peptides but is lacking for the wild-type peptides and that the mutated residues are processed, loaded, and presented on the I-A(b) molecule. Overall, our results illustrate that, although autoantibodies are generated against the endogenous protein, CD4 cells are activated through a neo-epitope recognition mechanism. Therefore, tolerance is maintained at a CD4 level but is broken at the level of antibody production. Finally, these results suggest that naturally occurring posttranslational modifications such as nitration may play a role in antibody-mediated autoimmune disorders.
Assuntos
Aminoácidos/imunologia , Linfócitos T CD4-Positivos/imunologia , Tolerância Imunológica/imunologia , Fator de Necrose Tumoral alfa/imunologia , Substituição de Aminoácidos , Aminoácidos/genética , Animais , Autoanticorpos/imunologia , Linfócitos T CD4-Positivos/metabolismo , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Fator de Crescimento Epidérmico/genética , Fator de Crescimento Epidérmico/imunologia , Fator de Crescimento Epidérmico/metabolismo , Epitopos/imunologia , Epitopos/metabolismo , Feminino , Imunização/métodos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Proteínas Mutantes/genética , Proteínas Mutantes/imunologia , Fenilalanina/análogos & derivados , Fenilalanina/genética , Fenilalanina/imunologia , Fatores de Tempo , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo , Tirosina/análogos & derivados , Tirosina/genética , Tirosina/imunologiaRESUMO
Stimulation via the T-cell receptor (TCR) activates p38α and p38ß by phosphorylation of p38 Tyr-323 (p38(Y323)). Here we characterize knockin mice in which p38α and/or ß Tyr-323 has been replaced with Phe. We find that p38α accounts for two-thirds and p38ß the remainder of TCR-induced p38 activation. T cells from double knockin mice (p38αß(Y323F)) had defects in TCR-mediated proliferation and Th1 and Th17 skewing, the former corresponding with an inability to sustain T-bet expression. Introduction of p38α(Y323F) into Gadd45α-deficient mice, in which the alternative p38 pathway is constitutively active, reversed T-cell hyperproliferation and autoimmunity. Furthermore, p38αß(Y323F) mice had delayed onset and reduced severity of the inflammatory autoimmune diseases collagen-induced arthritis and experimental autoimmune encephalomyelitis. Thus, T cell-specific alternative activation of p38 is an important pathway in T-cell proliferation, Th skewing, and inflammatory autoimmunity, and may be an attractive tissue-specific target for intervention in these processes.
Assuntos
Artrite Experimental/metabolismo , Autoimunidade , Proteínas de Ciclo Celular/genética , Encefalomielite Autoimune Experimental/metabolismo , Inflamação/metabolismo , Proteínas Nucleares/genética , Receptores de Antígenos de Linfócitos T/genética , Transdução de Sinais/imunologia , Linfócitos T/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/genética , Animais , Artrite Experimental/genética , Artrite Experimental/imunologia , Artrite Experimental/patologia , Western Blotting , Proteínas de Ciclo Celular/deficiência , Proteínas de Ciclo Celular/imunologia , Proliferação de Células , Encefalomielite Autoimune Experimental/genética , Encefalomielite Autoimune Experimental/imunologia , Encefalomielite Autoimune Experimental/patologia , Ativação Enzimática/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Técnicas de Introdução de Genes , Inflamação/genética , Inflamação/imunologia , Inflamação/patologia , Ativação Linfocitária , Camundongos , Camundongos Transgênicos , Proteínas Nucleares/deficiência , Proteínas Nucleares/imunologia , Fenilalanina/imunologia , Fenilalanina/metabolismo , Fosforilação , Receptores de Antígenos de Linfócitos T/imunologia , Receptores de Antígenos de Linfócitos T/metabolismo , Linfócitos T/imunologia , Tirosina/imunologia , Tirosina/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/imunologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismoRESUMO
Glycolate oxidase (GO) and ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO) are the two enzymes that serve key functions in the photorespiration and photosynthesis of plants. A 2 kDa highly basic phenylalanine-rich oligo-peptide (BOP) binds to the surface of acidic GO via ionic and hydrophobic interactions, forming the GO-BOP complex (GC). Previously, RubisCO was thought to exist as a single species composed of a large (rbc L, 54 kDa) and a small subunit (rbc S, 14 kDa). Here we show for the first time, using 2-DE, SDS-PAGE, immunoassays and amino acid determination, that BOP also interacts with RubisCO and that many RubisCO-BOP complexes (RCs), differing in pI, hydrophobicity and activity, coexist in green leaves. GCs, RCs and crude extract from green leaves analyzed by SDS-PAGE Western blotting showed that BOP exists either in subunit-BOP complexes (GO subunit-BOP, rbc L-BOP and rbc S-BOP etc.), with a wide variation in the number and the position of BOPs bound to each subunit molecular, or alone without a binding partner. When rbc L-BOP and rbc S-BOP were assayed by SDS-PAGE, BOP was dissociated from the subunit and it self-assembled to form 37 different BOP polymers (basic phenylalanine-rich protein) whose molecular weights (M(r)s) ranged from 34.0 to 91.6 kDa, indicating that the M(r) of BOP is about 2 kDa. Thus, the addition of BOP changes the M(r) of the subunit-BOP complexes so minimally that the rbc L and rbc S run at their predicted M(r)s on SDS-PAGE. In summary, the results described here demonstrate that the presence of BOP in complexes (both subunit-BOP complex and protein-BOP complex) can cause cross-reactivity of antibodies against different proteins.
Assuntos
Oxirredutases do Álcool/metabolismo , Oligopeptídeos/metabolismo , Fenilalanina/metabolismo , Oxirredutases do Álcool/antagonistas & inibidores , Oxirredutases do Álcool/química , Aminoácidos , Animais , Anticorpos/química , Anticorpos/imunologia , Anticorpos/metabolismo , Western Blotting , Brassica/química , Reações Cruzadas , Eletroforese em Gel de Poliacrilamida , Interações Hidrofóbicas e Hidrofílicas , Imunoensaio , Camundongos , Peso Molecular , Complexos Multiproteicos , Oligopeptídeos/química , Oligopeptídeos/imunologia , Fenilalanina/química , Fenilalanina/imunologia , Extratos Vegetais/química , Folhas de Planta/química , Reação em Cadeia da Polimerase , Subunidades Proteicas , Ribulose-Bifosfato Carboxilase/química , Ribulose-Bifosfato Carboxilase/metabolismoRESUMO
The binding site of a monoclonal anti-L-amino acid antibody (anti-L-AA) was modeled using the program SWISS-MODEL. Docking experiments with the enantiomers of phenylalanine revealed that the antibody interacts with L-phenylalanine via hydrogen bonds and hydrophobic contacts, whereas the D-enantiomer is rejected due to steric hindrance. Comparison of the sequences of this antibody and an anti-D-amino acid antibody (anti-D-AA) indicates that both immunoglobulins derived from the same germline progenitor. Substitution of four amino acids residues, three in the framework and one in the complementarity determining regions (CDRs), allowed in silico conversion of the anti-L-AA into an antibody that stereoselectively binds D-phenylalanine.
Assuntos
Anticorpos Monoclonais/química , Anticorpos Monoclonais/imunologia , Simulação por Computador , Modelos Moleculares , Fenilalanina/química , Fenilalanina/imunologia , Sequência de Aminoácidos , Reações Antígeno-Anticorpo , Sítios de Ligação , Dados de Sequência Molecular , Alinhamento de Sequência , EstereoisomerismoRESUMO
A vacuolar serine protease (Pen ch 18) has been identified as a major allergen of Penicillium chrysogenum. The molecular features of antigenic determinant(s) on Pen ch 18 recognized by human IgE antibodies, however, have remained unclear. Here, we show that a dominant IgE epitope on the N-terminally processed Pen ch 18 allergen was narrowed down to residues 83-91. In addition, Lys89, Lys90, and possibly Phe91 were identified as the core residues. Substitution of Lys89, Lys90, or Phe91 with alanine can significantly reduce IgE-binding to Pen ch 18. Immunoblot inhibition confirmed that Lys89 and Phe91 played a significant role in IgE-binding against Pen ch 18. Molecular modeling suggests they are located on a loop-like structure at or near the surface of the major fungal allergen.
Assuntos
Alérgenos/imunologia , Anticorpos Antifúngicos/imunologia , Proteínas Fúngicas/imunologia , Epitopos Imunodominantes/imunologia , Imunoglobulina E/imunologia , Penicillium chrysogenum/imunologia , Alérgenos/química , Alérgenos/genética , Mapeamento de Epitopos , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Humanos , Epitopos Imunodominantes/química , Epitopos Imunodominantes/genética , Lisina/genética , Lisina/imunologia , Mutação , Fenilalanina/genética , Fenilalanina/imunologia , Conformação Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologiaRESUMO
BACKGROUND: Raising selectivity to tumor cells is a major challenge for most chemotherapy drugs. One of approaches to realizing this goal is antibody-directed enzyme prodrug therapy (ADEPT). This study was done to investigate the curative effect of a new ADEPT system for the treatment of prostate cancer. METHODS: Methotrexate (MTX) prodrugs were synthesized and anti-seminoprotein (SM) single-chain antibody/human carboxypeptidase-A fusion protein (scFv/hCPA) was prepared. Therapeutic effects of this ADEPT system were evaluated. RESULTS: The synthesis of prodrugs was successful and the prodrugs were confirmed no cytotoxicity, but hydrolysis with tumor-targeted scFv/hCPA fusion protein gave 1,000-fold higher cytotoxicity than MTX-alpha-Phe only. Cell cycle assays showed that tumor cells were arrested in the S phase after ADEPT treatment; furthermore, tumors were inhibited significantly in scFv/hCPA and MTX-alpha-Phe treated mice. CONCLUSIONS: Our results suggest that targeted activation cytotoxicity against established prostate cancer by scFv/hCPA mediated ADEPT is tumor-specific and has no systemic toxicity in vitro and in vivo.
Assuntos
Carboxipeptidases A/uso terapêutico , Sistemas de Liberação de Medicamentos , Metotrexato/análogos & derivados , Fenilalanina/análogos & derivados , Pró-Fármacos/uso terapêutico , Neoplasias da Próstata/tratamento farmacológico , Proteínas Recombinantes de Fusão/uso terapêutico , Animais , Anticorpos Antineoplásicos/administração & dosagem , Anticorpos Antineoplásicos/farmacologia , Anticorpos Antineoplásicos/uso terapêutico , Carboxipeptidases A/administração & dosagem , Carboxipeptidases A/imunologia , Carboxipeptidases A/farmacologia , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Humanos , Região Variável de Imunoglobulina/administração & dosagem , Região Variável de Imunoglobulina/farmacologia , Região Variável de Imunoglobulina/uso terapêutico , Masculino , Metotrexato/administração & dosagem , Metotrexato/imunologia , Metotrexato/farmacologia , Metotrexato/uso terapêutico , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Transplante de Neoplasias , Células-Tronco Neoplásicas , Fenilalanina/administração & dosagem , Fenilalanina/imunologia , Fenilalanina/farmacologia , Fenilalanina/uso terapêutico , Pró-Fármacos/administração & dosagem , Pró-Fármacos/farmacologia , Antígeno Prostático Específico/imunologia , Neoplasias da Próstata/imunologia , Neoplasias da Próstata/patologia , Proteínas Recombinantes de Fusão/administração & dosagem , Proteínas Recombinantes de Fusão/farmacologia , Transplante HeterólogoRESUMO
1. We investigated the effect of bisphenol A (BPA), which binds estrogen receptors, on immune responses including production of antigen-specific antibodies, proliferative responses of lymphoid cells, and Th1 and Th2 responses. 2. For this investigation, mice were p.o. given varying doses including 3, 30, 300, and 3000 micro g kg(-1) of BPA immediately after immunization with hen egg lysozyme (HEL) (day 0) and then daily by day 20. On day 21, anti-HEL IgG antibodies in sera and proliferative responses of spleen cells to the antigen were measured. Anti-HEL IgG2a antibodies and IFN-gamma secreted from splenic lymphocytes were also measured as indicators of Th1 immune responses, while anti-HEL IgG1 antibodies and IL-4, as those of Th2 responses. 3. The results showed that treatment with 3000 micro g kg(-1) of BPA was followed by a significant increase in anti-HEL IgG as well as the antigen-specific cell proliferation. Anti-HEL IgG2a production and IFN-gamma secretion were significantly enhanced in mice treated with 300 and 30 micro g kg(-1) of BPA, respectively, while anti-HEL IgG1 production and IL-4 secretion were augmented in animals given 3000 and 300 micro g kg(-1) of the chemical, respectively. 4. Augmentation of these immune responses was also observed in mice exposed to 0.3-30 micro g kg(-1) of estradiol, although Th1 responses appeared to be more sensitive to the sex hormone than Th2 responses. 5. These results suggest that BPA may play a role in augmenting immune responses, especially Th1 responses.
Assuntos
Formação de Anticorpos/efeitos dos fármacos , Compostos de Boro/administração & dosagem , Compostos de Boro/imunologia , Epitopos/efeitos dos fármacos , Imunoglobulina G/biossíntese , Linfócitos/efeitos dos fármacos , Fenóis/farmacologia , Fenilalanina/análogos & derivados , Fenilalanina/administração & dosagem , Fenilalanina/imunologia , Células Th1/efeitos dos fármacos , Células Th1/fisiologia , Células Th2/efeitos dos fármacos , Células Th2/fisiologia , Animais , Formação de Anticorpos/imunologia , Formação de Anticorpos/fisiologia , Compostos Benzidrílicos , Epitopos/imunologia , Epitopos/fisiologia , Feminino , Linfócitos/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos DBA , Fenóis/imunologia , Baço/efeitos dos fármacos , Baço/metabolismoRESUMO
We determined if a single amino acid substitution in a self protein causes autoantibody responses. Mouse lysozyme (ML) was used as a model self protein, and a mutant ML (F57L ML) was prepared by replacing 57Phe of ML to Leu, an approach which resulted in introducing into ML the immunogenic sequence of peptide 50-61 of hen egg lysozyme (HEL) restricted to I-A(k) MHC class II molecule. We found that F57L ML but not native ML primed HEL specific T cells and triggered ML specific autoantibody responses in B10.A and C3H mice (I-A(k), I-E(k)). Peptide regions, ML 14-69 and ML 98-130, were major epitopes of autoantibodies in both strains of mice. These findings indicate that a single amino acid substitution in self proteins can cause an autoantibody response when the mutated region is presented by MHC class II molecules and recognized by T cells.